SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs >

Abbvie (ABBV)

ABBV RSS Feed
Add ABBV Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board:
Last Post: 12/3/2016 8:23:08 PM - Followers: 33 - Board type: Free - Posts Today: 0

ABBV is the branded-pharmaceuticals business formely
owned by Abbott that is now fully independent.


ABBV Investor Relations

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ABBV
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ABBV News: European Commission Grants Conditional Marketing Approval for AbbVie's VENCLYXTO™ (venetoclax) Monotherapy for Appropriate ... 01:00 AM
ABBV News: Late-Breaking Ibrutinib (IMBRUVICA®) Data Show Complete or Partial Response in Two-Thirds of Patients with Chronic Graft-Ver... 12/06/2016 10:30:00 AM
ABBV News: New Phase 2 Data Show Nearly Half of Patients with Relapsed/Refractory Marginal Zone Lymphoma (MZL) Respond to Treatment with... 12/05/2016 09:15:00 PM
ABBV News: AbbVie and Johns Hopkins to Collaborate on Cancer Research 12/05/2016 08:55:00 AM
ABBV News: AbbVie and Northwestern University's Lurie Cancer Center to collaborate on multi-year cancer research agreement 12/05/2016 08:50:00 AM
News News Alert: European Commission Grants Conditional Marketing Approval for AbbVie's VENCLYXTO™ (venetoclax) Monotherapy for Appropriate ... 12/08/2016 01:00:00 AM
PostSubject
#290  Sticky Note ABBV/ENTA report 8w Glecaprevir/Pibrentasvir phase-3 data from three trials: DewDiligence 11/11/16 08:48:34 AM
#293   Imbruvica shows impressive activity in CLL/SLL after 5 years: DewDiligence 12/03/16 08:23:08 PM
#292   MRK’s 3-DAA HCV regimen fails to impress: #msg-126517784. DewDiligence 11/13/16 10:44:09 AM
#291   ABBV makes this bit.ly/2frudVN Stock Screen : Top dividend ValueInvestor15 11/11/16 12:55:47 PM
#290   ABBV/ENTA report 8w Glecaprevir/Pibrentasvir phase-3 data from three trials: DewDiligence 11/11/16 08:48:34 AM
#289   USPTO rules for ABBV—against CHRS—on Humira ‘166 patent: DewDiligence 11/07/16 12:35:46 PM
#288   ABBV reports 3Q16 results: DewDiligence 10/28/16 08:04:54 AM
#287   AMGN not launching Amjevita—(Humira FoB)—until 2018 or later: DewDiligence 10/27/16 06:47:26 PM
#286   Musings on GILD’s POLARIS studies of 3-DAA HCV regimen: DewDiligence 10/20/16 12:22:22 PM
#285   Leerink initiated AbbVie ABBV at Market Perform. Agree... ValueInvestor15 10/18/16 11:03:06 AM
#284   ABBV/ENTA's second-generation HCV regimen gets FDA BTD for DewDiligence 09/30/16 08:20:09 AM
#283   FDA approves AMGN’s Humira biosimilar: DewDiligence 09/23/16 07:14:06 PM
#280   2Q16 Harvoni/Viekira/Zepatier sales in US/EU/Japan: #msg-124194472. DewDiligence 07/29/16 02:34:39 PM
#279   ABBV 2Q16 results: DewDiligence 07/29/16 09:40:23 AM
#278   AbbVie (ABBV), also reporting Friday, is still ahead fuzzy 07/24/16 08:31:50 AM
#277   FDA approves Humira for NIU: DewDiligence 06/30/16 09:18:29 PM
#276   Most investors think they did, evidently. DewDiligence 06/06/16 10:55:12 AM
#275   Did AbbVie Overpay For Stemcentrx In The $10 venturecapp 06/06/16 10:54:17 AM
#274   ABBV R&D Day slides (247 pages); DewDiligence 06/03/16 09:32:13 AM
#273   FDA approves Zinbryta (daclizumab) for MS: DewDiligence 05/27/16 06:18:05 PM
#272   Yeah I saw that and it def stood PennyStockPickz 04/30/16 02:25:32 PM
#271   ABBV acquires Stemcentryx for $5.8B in cash & DewDiligence 04/28/16 09:29:14 AM
#270   ABBV inked two oncology deals today: DewDiligence 04/21/16 04:17:49 PM
#269   Global phase-3 program for ABT-493/ABT-530 (10 phase-3 trials, DewDiligence 04/19/16 03:41:05 PM
#268   Twitter poll re ABBV's priority-review voucher: DewDiligence 04/18/16 04:03:11 PM
#267   ABT-493/ABT-530 data released today are as good as DewDiligence 04/16/16 11:28:53 AM
#266   FDA approves Imbruvica for first-line CLL: DewDiligence 03/04/16 01:29:56 PM
#265   $ABBV Daily and Weekly Charts http://www.stock $Pistol Pete$ 02/18/16 09:32:32 PM
#264   Partial funding by ABBV: north40000 02/18/16 10:54:31 AM
#263   $ABBV Daily Chart http://www.stockcharts.com/c $Pistol Pete$ 02/14/16 05:25:32 PM
#262   Two IPOs to Kick off 2016 in Biotech nyctraydr 02/10/16 01:54:26 PM
#261   4Q15 V-Pak sales $554M: #msg-120164111. DewDiligence 01/29/16 07:59:36 AM
#260   FDA approves MRK’s HCV combo with recommended RAV DewDiligence 01/28/16 06:27:02 PM
#259   Phase-3 program for ABT-494 in RA: #msg-119708677. DewDiligence 01/08/16 03:44:07 PM
#258   MRK’s HCV regimen delayed slightly in EU: #msg-119266731. DewDiligence 12/18/15 10:26:50 AM
#257   FDA accepts NDA for qD formulation of V-Pak: #msg-118870098. DewDiligence 12/02/15 09:46:19 AM
#256   ABT-493/ABT-530 phase-2b data from AASLD: #msg-118523846. DewDiligence 11/16/15 09:59:52 AM
#255   Musings on Humira’s patent estate: #msg-118144295. DewDiligence 10/31/15 12:16:28 PM
#254   ABBV’s PR on 5-year (2015-2020) outlook (to accompany DewDiligence 10/30/15 12:16:33 PM
#253   ABBV CC slides on 5-year outlook (2015-2020): DewDiligence 10/30/15 10:42:06 AM
#252   3Q15 V-Pak sales of $469M increased 21% vs 2Q15: DewDiligence 10/30/15 08:46:34 AM
#251   Newsworthy HCV items from GILD’s 3Q15 CC: DewDiligence 10/27/15 05:31:12 PM
#250   ABBV’s PR on V-Pak label change: #msg-117923678. DewDiligence 10/22/15 06:59:27 PM
#249   ABBV/ENTA's AASLD line-up includes oral presentations with SVR4 DewDiligence 10/01/15 04:59:23 PM
#248   ABBV/ENTA’s Viekierax receives Japanese approval for GT1b patients: DewDiligence 09/28/15 05:31:08 AM
#247   M&A-minded AbbVie snaps up JPMorgan's dealmaking hotshot Bickema 09/17/15 09:19:50 PM
#246   ABBV advances Elagolix to phase-3 in uterine fibroids: DewDiligence 09/16/15 11:44:47 AM
#245   ABBV submits sNDA for Imbruvica in first-line CLL: #msg-116950612. DewDiligence 09/14/15 09:34:06 AM
#244   FDA grants priority review for Empliciti in second-line DewDiligence 09/01/15 10:25:10 AM
#243   Medicaid should be treating more HCV patients, say DewDiligence 08/25/15 06:29:55 PM
#242   ABBV pays record $350M for priority-review voucher: DewDiligence 08/19/15 09:23:54 AM
PostSubject